Short-Term Pulmonary, Immunologic, Or Coagulation Status Unaffected By Duration Of RBC Storage

Main Category: Blood / Hematology
Also Included In: Respiratory / Asthma
Article Date: 24 Jan 2012 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


There is no difference in early measures of pulmonary function, immunologic status or coagulation status after fresh versus standard issue single-unit red blood cell (RBC) transfusion, according to a new study from the Mayo Clinic.

"Longer duration of RBC storage is thought to increase the risk of transfusion-related pulmonary complications," said Daryl J. Kor, assistant professor of anesthesiology at the Mayo Clinic College of Medicine. "In our study of 100 intubated, mechanically ventilated patients, we did not see evidence for an increased risk associated with RBC storage duration, at least not in the early post-transfusion period."

The findings were published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

In the double-blind trial, 50 patients were randomized to receive fresh (median storage duration = 4.0 days) RBC and 50 were randomized to receive standard issue RBC (median storage duration = 26.5 days). The primary outcome measure was change in pulmonary gas exchange, as measured by the partial pressure of arterial oxygen to fraction of inspired oxygen concentration ratio (-PaO2/FiO2). Post-transfusion measurements were performed upon completion of the transfusion and within two hours of the transfusion (median 1.9 hours in the fresh RBC group and 1.8 hours in the standard issue RBC group).

No significant differences between groupswere seen in the primary outcome measure of change in PaO2/FiO2 ratio (2.5 +/- 49.3 vs. -9.0 +/- 69.8; fresh RBC vs. standard issue RBC; p = 0.22). Similarly, no significant differences were seen for any of the other outcome measures of pulmonary function (fraction of dead space ventilation, dynamic and static pulmonary compliance), immunologic status (tumor necrosis factor-alpha, interleukin-8, C-reactive protein) or coagulation status (fibrinogen, anti-thrombin consumption).

"Our data do not support a significant effect of RBC storage duration on respiratory, immunologic or coagulation parameters in the immediate post-transfusion period," said Dr. Kor. "Previous observational studies linking RBC storage duration and respiratory complications may have suffered from bias and unmeasured confounding, which were more effectively addressed in our double-blind, randomized trial study design."

The study did have some limitations, including the short duration of follow-up, the study's limited sample size and the single center, tertiary-care setting, which may limit the generalizability of the results.

"Given the lack of an association between RBC storage duration and evidence of transfusion-related pulmonary complications in our study, randomization to fresh versus longer storage duration RBC in clinical trials would clearly seem ethical," said Dr. Kor. "Further study will need to clarify the impact of RBC storage duration on other patient-centered outcomes."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our blood / hematology section for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
American Thoracic Society. "Short-Term Pulmonary, Immunologic, Or Coagulation Status Unaffected By Duration Of RBC Storage." Medical News Today. MediLexicon, Intl., 24 Jan. 2012. Web.
22 Feb. 2012. <http://www.medicalnewstoday.com/releases/240606.php>

APA
American Thoracic Society. (2012, January 24). "Short-Term Pulmonary, Immunologic, Or Coagulation Status Unaffected By Duration Of RBC Storage." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/240606.php.

Please note: If no author information is provided, the source is cited instead.


Blood / Hematology

What is Hemophilia?

Hemophilia is a group of inherited blood disorders in which the blood does not clot properly. Bleeding disorders are due to defects in the blood vessels, the coagulation mechanism, or the blood platelets. Read more...

Most Popular Articles



Follow Our Blood News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Blood / Hematology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »